• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强直性脊柱炎髋关节病的发病机制:异常髓过氧化物酶和吞噬体。

Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and Phagosome.

机构信息

Spine and Osteopathy Ward, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

出版信息

Front Immunol. 2021 Nov 22;12:572592. doi: 10.3389/fimmu.2021.572592. eCollection 2021.

DOI:10.3389/fimmu.2021.572592
PMID:34880852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8647161/
Abstract

BACKGROUND

The pathogenesis of Ankylosing spondylitis (AS) has not been elucidated, especially involving hip joint disease. The purpose of this study was to analyze the proteome of diseased hip in AS and to identify key protein biomarkers.

MATERIAL AND METHODS

We used label-free quantification combined with liquid chromatography mass spectrometry (LC-MS/MS) to screen for differentially expressed proteins in hip ligament samples between AS and No-AS groups. Key protein was screened by Bioinformatics methods. and verified by experiments.

RESULTS

There were 3,755 identified proteins, of which 92.916% were quantified. A total of 193 DEPs (49 upregulated proteins and 144 downregulated proteins) were identified according to P < 0.01 and Log|FC| > 1. DEPs were mainly involved in cell compartment, including the vacuolar lumen, azurophil granule, primary lysosome, etc. The main KEGG pathway included Phagosome, Glycerophospholipid metabolism, Lysine degradation, Pentose phosphate pathway. Myeloperoxidase (MPO) was identified as a key protein involved in Phagosome pathway. The experiment of siRNA interfering with cells further confirmed that the upregulated MPO may promote the inflammatory response of fibroblasts.

CONCLUSIONS

The overexpression of MPO may contribute to the autoimmune inflammatory response of AS-affected hip joint through the phagosome pathway.

摘要

背景

强直性脊柱炎(AS)的发病机制尚未阐明,特别是涉及髋关节疾病。本研究旨在分析 AS 患者髋关节疾病的蛋白质组,并鉴定关键蛋白生物标志物。

材料和方法

我们使用无标记定量结合液相色谱-质谱联用(LC-MS/MS)技术筛选 AS 组和非 AS 组髋关节韧带样本中的差异表达蛋白。通过生物信息学方法筛选关键蛋白,并通过实验进行验证。

结果

共鉴定出 3755 种蛋白质,其中 92.916%可定量。根据 P<0.01 和 Log|FC|>1,共鉴定出 193 个差异表达蛋白(49 个上调蛋白和 144 个下调蛋白)。差异表达蛋白主要参与细胞区室,包括液泡腔、嗜天青颗粒、初级溶酶体等。主要的 KEGG 途径包括吞噬体、甘油磷脂代谢、赖氨酸降解、戊糖磷酸途径。髓过氧化物酶(MPO)被鉴定为参与吞噬体途径的关键蛋白。siRNA 干扰细胞的实验进一步证实,上调的 MPO 可能通过吞噬体途径促进成纤维细胞的炎症反应。

结论

MPO 的过表达可能通过吞噬体途径促进 AS 受累髋关节的自身免疫炎症反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/0c5f955de484/fimmu-12-572592-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/74c6f989b1e4/fimmu-12-572592-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/f400ab367fb2/fimmu-12-572592-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/3d28e12ddf0d/fimmu-12-572592-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/6ef446fc77e9/fimmu-12-572592-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/79036112a097/fimmu-12-572592-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/7e0b1e8f27b1/fimmu-12-572592-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/b9fe5c5c5585/fimmu-12-572592-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/bd5f29a7717c/fimmu-12-572592-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/dcd99dc72236/fimmu-12-572592-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/0c5f955de484/fimmu-12-572592-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/74c6f989b1e4/fimmu-12-572592-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/f400ab367fb2/fimmu-12-572592-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/3d28e12ddf0d/fimmu-12-572592-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/6ef446fc77e9/fimmu-12-572592-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/79036112a097/fimmu-12-572592-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/7e0b1e8f27b1/fimmu-12-572592-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/b9fe5c5c5585/fimmu-12-572592-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/bd5f29a7717c/fimmu-12-572592-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/dcd99dc72236/fimmu-12-572592-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b468/8647161/0c5f955de484/fimmu-12-572592-g010.jpg

相似文献

1
Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and Phagosome.强直性脊柱炎髋关节病的发病机制:异常髓过氧化物酶和吞噬体。
Front Immunol. 2021 Nov 22;12:572592. doi: 10.3389/fimmu.2021.572592. eCollection 2021.
2
Up-regulation of fatty acid oxidation in the ligament as a contributing factor of ankylosing spondylitis: A comparative proteomic study.韧带中脂肪酸氧化上调作为强直性脊柱炎的一个促成因素:一项比较蛋白质组学研究。
J Proteomics. 2015 Jan 15;113:57-72. doi: 10.1016/j.jprot.2014.09.014. Epub 2014 Oct 2.
3
Changes in gene expression profiles of the hip joint ligament of patients with ankylosing spondylitis revealed by DNA chip.DNA 芯片揭示强直性脊柱炎患者髋关节韧带基因表达谱的变化。
Clin Rheumatol. 2012 Oct;31(10):1479-91. doi: 10.1007/s10067-012-2038-9. Epub 2012 Aug 18.
4
PDGFRB as a potential therapeutic target of ankylosing spondylitis: validation following bioinformatics analysis.血小板衍生生长因子受体 B 作为强直性脊柱炎潜在治疗靶点的生物信息学分析验证。
Cell Mol Biol (Noisy-le-grand). 2020 Sep 30;66(6):127-134.
5
Increased CCL19 and CCL21 levels promote fibroblast ossification in ankylosing spondylitis hip ligament tissue.趋化因子CCL19和CCL21水平升高促进强直性脊柱炎髋关节韧带组织中的成纤维细胞骨化。
BMC Musculoskelet Disord. 2014 Sep 26;15:316. doi: 10.1186/1471-2474-15-316.
6
Plasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profiles.血浆、尿液和韧带组织代谢物谱分析利用基于核磁共振的代谢谱揭示强直性脊柱炎的潜在生物标志物。
Arthritis Res Ther. 2016 Oct 22;18(1):244. doi: 10.1186/s13075-016-1139-2.
7
Involvement of Notch1/Hes signaling pathway in ankylosing spondylitis.Notch1/Hes信号通路在强直性脊柱炎中的作用
Int J Clin Exp Pathol. 2015 Mar 1;8(3):2737-45. eCollection 2015.
8
Anti-TNF Therapy Regulates Phagosome Pathway by Inhibiting NCF4 Expression to Treat Ankylosing Spondylitis.抗 TNF 治疗通过抑制 NCF4 表达调控吞噬体通路治疗强直性脊柱炎。
J Musculoskelet Neuronal Interact. 2023 Sep 1;23(3):355-364.
9
Profiling and Bioinformatics Analysis of Differentially Expressed circRNAs in Spinal Ligament Tissues of Patients with Ankylosing Spondylitis.强直性脊柱炎患者脊柱韧带组织差异表达 circRNAs 的分析与生物信息学研究。
Biomed Res Int. 2020 Jun 14;2020:7165893. doi: 10.1155/2020/7165893. eCollection 2020.
10
Dysregulation of SAA1, TUBA8 and Monocytes Are Key Factors in Ankylosing Spondylitis With Femoral Head Necrosis.SAA1、TUB8 失调和单核细胞是伴股骨头坏死的强直性脊柱炎的关键因素。
Front Immunol. 2022 Jan 18;12:814278. doi: 10.3389/fimmu.2021.814278. eCollection 2021.

引用本文的文献

1
Proteomics signatures associated with hip arthropathy in ankylosing spondylitis.与强直性脊柱炎髋关节病相关的蛋白质组学特征
Front Med (Lausanne). 2025 May 14;12:1556118. doi: 10.3389/fmed.2025.1556118. eCollection 2025.
2
Significant correlations of upregulated MPO expression with cytokine imbalance in ankylosing spondylitis patients and the inhibitory effect mediated by mesenchymal stem cells.强直性脊柱炎患者中MPO表达上调与细胞因子失衡的显著相关性以及间充质干细胞介导的抑制作用。
BMC Musculoskelet Disord. 2025 Mar 1;26(1):212. doi: 10.1186/s12891-025-08458-6.
3
Is palmoplantar pustulosis combined with hip involvement a SAPHO syndrome?

本文引用的文献

1
Proteomics of epicardial adipose tissue in patients with heart failure.心肌脂肪组织蛋白质组学与心力衰竭患者。
J Cell Mol Med. 2020 Jan;24(1):511-520. doi: 10.1111/jcmm.14758. Epub 2019 Oct 31.
2
Ankylosing spondylitis: etiology, pathogenesis, and treatments.强直性脊柱炎:病因、发病机制及治疗方法
Bone Res. 2019 Aug 5;7:22. doi: 10.1038/s41413-019-0057-8. eCollection 2019.
3
Neutrophils in Psoriasis.银屑病中的中性粒细胞。
掌跖脓疱病合并髋关节受累是否为滑膜炎、痤疮、脓疱病、骨肥厚、骨髓炎综合征?
Postepy Dermatol Alergol. 2024 Jun;41(3):328-330. doi: 10.5114/ada.2024.141097. Epub 2024 Jun 30.
4
Causality between Ankylosing Spondylitis and osteoarthritis in European ancestry: a bidirectional Mendelian randomization study.欧洲裔人群中强直性脊柱炎与骨关节炎之间的因果关系:一项双向孟德尔随机化研究。
Front Immunol. 2024 Feb 6;15:1297454. doi: 10.3389/fimmu.2024.1297454. eCollection 2024.
5
Construction of a predictive model for blood transfusion in patients undergoing total hip arthroplasty and identification of clinical heterogeneity.构建全髋关节置换术患者输血预测模型及识别临床异质性。
Sci Rep. 2024 Jan 6;14(1):724. doi: 10.1038/s41598-024-51240-2.
6
Fibroblast Insights into the Pathogenesis of Ankylosing Spondylitis.成纤维细胞对强直性脊柱炎发病机制的见解
J Inflamm Res. 2023 Dec 22;16:6301-6317. doi: 10.2147/JIR.S439604. eCollection 2023.
7
Proteomic analysis to identification of hypoxia related markers in spinal tuberculosis: a study based on weighted gene co-expression network analysis and machine learning.基于加权基因共表达网络分析和机器学习的脊柱结核缺氧相关标志物的蛋白质组学分析:一项研究
BMC Med Genomics. 2023 Jun 20;16(1):142. doi: 10.1186/s12920-023-01566-z.
8
Radix for Ankylosing Spondylitis: Determining Potential Inflammatory Molecular Targets and Mechanism Using Network Pharmacology.基于网络药理学方法的治疗强直性脊柱炎的潜在炎症分子靶点和作用机制的研究。
Biomed Res Int. 2022 Sep 13;2022:3816258. doi: 10.1155/2022/3816258. eCollection 2022.
9
Exploration of the Immuno-Inflammatory Potential Targets of Xinfeng Capsule in Patients with Ankylosing Spondylitis Based on Data Mining, Network Pharmacology, and Molecular Docking.基于数据挖掘、网络药理学和分子对接技术探索新风胶囊治疗强直性脊柱炎的免疫炎症潜在靶点
Evid Based Complement Alternat Med. 2022 Mar 23;2022:5382607. doi: 10.1155/2022/5382607. eCollection 2022.
Front Immunol. 2019 Oct 9;10:2376. doi: 10.3389/fimmu.2019.02376. eCollection 2019.
4
Incidence of inflammatory bowel disease in patients with ankylosing spondylitis.强直性脊柱炎患者中炎症性肠病的发病率。
Ann Rheum Dis. 2021 Sep;80(9):e144. doi: 10.1136/annrheumdis-2019-216362. Epub 2019 Oct 14.
5
Mass Spectrometry for Proteomics-Based Investigation.基于质谱的蛋白质组学研究
Adv Exp Med Biol. 2019;1140:1-26. doi: 10.1007/978-3-030-15950-4_1.
6
Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease.髓过氧化物酶-连接炎症、氧化应激与心血管疾病的桥梁。
Clin Chim Acta. 2019 Jun;493:36-51. doi: 10.1016/j.cca.2019.02.022. Epub 2019 Feb 21.
7
Incidence of Total Hip and Knee Replacement in UK Patients with Ankylosing Spondylitis.英国强直性脊柱炎患者全髋关节和膝关节置换的发病率。
J Rheumatol. 2018 Aug;45(9):1334-1336. doi: 10.3899/jrheum.171387.
8
[Pathophysiology of aseptic femoral head necrosis: Pathogenesis and histopathological differential diagnosis].无菌性股骨头坏死的病理生理学:发病机制与组织病理学鉴别诊断
Orthopade. 2018 Sep;47(9):710-716. doi: 10.1007/s00132-018-3608-6.
9
Diagnostic Delay in Ankylosing Spondylitis: Related Factors and Prognostic Outcomes.强直性脊柱炎的诊断延迟:相关因素及预后结果
Arch Rheumatol. 2015 Aug 16;31(1):24-30. doi: 10.5606/ArchRheumatol.2016.5562. eCollection 2016 Mar.
10
Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives.髓过氧化物酶作为一种活性疾病生物标志物:最新的生化与病理学观点
Med Sci (Basel). 2018 Apr 18;6(2):33. doi: 10.3390/medsci6020033.